Crossject Société Anonyme reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 12.83 million compared to EUR 9.72 million a year ago. Net loss was EUR 8.47 million compared to EUR 11.16 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.135 EUR | -4.26% | +5.08% | -56.34% |
May. 03 | Crossject: praised for extended agreement on Zepizure | CF |
May. 02 | Crossject Signs A Geographic Extension of ZEPIZURE Commercialization Agreement in Europe | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-56.34% | 91.35M | |
-1.12% | 209M |
- Stock Market
- Equities
- ALCJ Stock
- News Crossject
- Crossject Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023